KATIE VOGT: Open Payments
NPI 1154882462 · OSAWATOMIE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 65 payments from 17 companies in 2025. Trend: 2023 $657 · 2024 $442 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $213 |
| Novo Nordisk Inc | 14 | $204 |
| Lilly USA, LLC | 11 | $149 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| PFIZER INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| LEO Pharma Inc. | 2 | $51 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
Products named: Wegovy, MOUNJARO, GEMTESA, QULIPTA, VRAYLAR, INSPIRE, Kerendia, UBRELVY.
Industry payments across KS — which companies pay providers there.
